484 related articles for article (PubMed ID: 16531014)
1. Nitrofurantoin: an effective and ignored antimicrobial.
Arya SC; Agarwal N; Agarwal S
Int J Antimicrob Agents; 2006 Apr; 27(4):354-5. PubMed ID: 16531014
[No Abstract] [Full Text] [Related]
2. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Arya SC; Agarwal N
BJU Int; 2009 Apr; 103(7):994-5. PubMed ID: 19302136
[No Abstract] [Full Text] [Related]
3. Clinical implications. In vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
[No Abstract] [Full Text] [Related]
4. Nitrofurantoin and pregnancy.
Cimolai N; Cimolai T
CMAJ; 2007 Jun; 176(13):1860-1. PubMed ID: 17576987
[No Abstract] [Full Text] [Related]
5. Agranulocytosis associated with nitrofurantoin therapy.
Roberts AD; Neelamegam M
Ann Pharmacother; 2005 Jan; 39(1):198. PubMed ID: 15572603
[No Abstract] [Full Text] [Related]
6. [Safety of nitrofurantoin in pregnancy].
Urbina O; Ferrández O; Salas E; Grau S
Enferm Infecc Microbiol Clin; 2010; 28(6):403. PubMed ID: 20430481
[No Abstract] [Full Text] [Related]
7. Can pregnant patients safely take nitrofurantoin?
Koren G
Can Fam Physician; 1996 Feb; 42():245-6. PubMed ID: 9222573
[No Abstract] [Full Text] [Related]
8. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
9. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
Anderson K
Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
[No Abstract] [Full Text] [Related]
10. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Cahen P; Honderlick P
Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity data in support of nitrofurantoin three times per day.
Amábile-Cuevas CF; Arredondo-García JL
J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023
[No Abstract] [Full Text] [Related]
12. The role of clinical guidelines.
Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
[No Abstract] [Full Text] [Related]
13. [Efficacy of nitrofurantoin in the treatment of chronic urinary tract infections in patients with type 2 diabetes mellitus].
Mozdzan M; Ruxer J; Siejka A; Loba J; Markuszewski L
Pol Merkur Lekarski; 2006 Nov; 21(125):434-8. PubMed ID: 17345835
[TBL] [Abstract][Full Text] [Related]
14. Increasing in vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
[No Abstract] [Full Text] [Related]
15. Nitrofurantoin neuropathy: a forgotten adverse effect.
Kammire LD; Donofrio PD
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):510-2. PubMed ID: 17666646
[TBL] [Abstract][Full Text] [Related]
16. In vitro resistance of E coli to TMP/SMX and clinical failure.
Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
[No Abstract] [Full Text] [Related]
17. [Liver cirrhosis due to chronic use of nitrofurantoin].
Volbeda F; Jonker AM; Vecht J; Groeneveld PH
Ned Tijdschr Geneeskd; 2004 Jan; 148(5):235-8. PubMed ID: 14983581
[TBL] [Abstract][Full Text] [Related]
18. Urinary antiseptics.
Br Med J; 1968 Jun; 2(5608):812-4. PubMed ID: 4872850
[No Abstract] [Full Text] [Related]
19. Extended therapy in patients with established urinary tract infection.
Lawson DH; Gleadle RI; Linton AL
Scott Med J; 1971 Mar; 16(3):169-72. PubMed ID: 4933924
[No Abstract] [Full Text] [Related]
20. [Therapy of acute uncomplicated urinary tract infection using a nitrofurantoin combination].
Taupitz E
Med Welt; 1972 May; 23(20):771-2. PubMed ID: 5037196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
